title: Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
authors.forename: Samir
authors.initials: S
authors.lastname: Patel
authors.forename: Delong
authors.initials: D
authors.lastname: Liu
authors.forename: Philip
authors.initials: P
authors.lastname: Caron
authors.forename: Karen
authors.initials: K
authors.lastname: Seiter
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy*; D007421:Intestine, Small / Q000473:pathology*; D000077146:Irinotecan; D002955:Leucovorin / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction
chemical_list: D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin